Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)

Hubei Biocause Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Investments in Debt Securities	36,994	38,435	35,490	36,547	34,091	27,806
Investments in Equity & Preferred Securities	87,336	97,160	95,756	79,715	85,134	92,733
Policy Loans	1,202	1,114	946.6	902.64	838.81	628.67
Other Investments	2,798	1,109	5,563	4,499	1,656	3,370
Total Investments	150,132	159,101	151,039	135,297	135,638	135,887
Cash & Equivalents	11,008	28,154	26,309	23,250	26,857	12,992
Reinsurance Recoverable	251.5	257.84	249.72	2,037	3,466	1,940
Other Receivables	96,491	93,938	84,480	77,518	49,054	38,874
Separate Account Assets	4,433	4,656	5,154	5,992	4,434	2,817
Property, Plant & Equipment	1,467	1,291	844.07	830.33	580.44	567.17
Goodwill	6,193	6,193	6,192	6,192	6,192	6,186
Other Intangible Assets	265.8	283.2	299.34	269.71	190	109.42
Other Current Assets	4,369	4,149	10,523	10,224	10,716	3,672
Long-Term Deferred Tax Assets	2,230	2,654	2,280	1,010	976.19	944.16
Long-Term Deferred Charges	16.36	19.4	25.92	31.38	-	25.15
Other Long-Term Assets	1,438	1,241	1,201	1,251	1,298	1,259
Total Assets	278,294	301,936	288,599	263,904	239,403	205,274
Accounts Payable	615.15	949.05	206.9	93.51	35.01	156.51
Accrued Expenses	574.23	591.64	1,132	1,239	906.58	786.62
Insurance & Annuity Liabilities	216,942	231,001	215,704	199,703	187,869	158,624
Unpaid Claims	3,274	2,808	1,133	1,089	858.86	675.49
Unearned Premiums	32.41	13.93	182.58	238.08	95.3	29.69
Reinsurance Payable	213.71	217.59	225.77	206.87	1,080	85.8
Short-Term Debt	10,930	18,248	21,190	9,426	4,584	6,180
Current Income Taxes Payable	11.03	9.9	11.91	23.83	7.76	202.84
Long-Term Debt	5,510	7,099	6,791	6,132	2,868	-
Long-Term Leases	58.79	71.56	89.58	111.18	-	-
Long-Term Deferred Tax Liabilities	1,384	1,378	1,348	1,281	1,519	1,049
Separate Account Liability	4,433	4,656	5,154	5,992	4,434	2,817
Other Current Liabilities	899.65	1,217	761.4	844	555.17	295.27
Other Long-Term Liabilities	38.21	37.36	56.48	42.09	1.43	17.38
Total Liabilities	244,919	268,302	253,996	226,429	204,815	170,920
Common Stock	4,941	4,941	4,941	4,941	4,941	4,941
Additional Paid-In Capital	11,010	11,041	11,094	11,094	11,095	11,095
Retained Earnings	5,223	5,588	6,783	6,533	6,112	6,026
Comprensive Income & Other	-712.08	-978.79	-1,405	-15.1	-1,013	-838.78
Total Common Equity	20,461	20,590	21,412	22,553	21,135	21,223
Minority Interest	12,914	13,044	13,191	14,921	13,453	13,130
Shareholders' Equity	33,375	33,634	34,603	37,475	34,588	34,353
Total Liabilities & Equity	278,294	301,936	288,599	263,904	239,403	205,274
Filing Date Shares Outstanding	4,941	4,941	4,941	4,941	4,941	4,941
Total Common Shares Outstanding	4,941	4,941	4,941	4,941	4,941	4,941
Total Debt	16,499	25,419	28,070	15,669	7,452	6,180
Net Cash (Debt)	-5,491	2,735	-1,760	7,582	19,405	6,812
Net Cash Growth	-	-	-	-60.93%	184.87%	-49.77%
Net Cash Per Share	-1.10	0.55	-0.39	1.61	4.01	1.38
Book Value Per Share	4.14	4.17	4.33	4.56	4.28	4.30
Tangible Book Value	14,003	14,114	14,920	16,091	14,753	14,927
Tangible Book Value Per Share	2.83	2.86	3.02	3.26	2.99	3.02
Buildings	1,490	1,292	702.83	633.87	481.32	463.3
Machinery	96.84	90.97	86.15	79.67	64.34	54.75
Construction In Progress	0.72	3.38	95.45	95.9	102.34	99.65

Source: S&P Capital IQ. Insurance template. Financial Sources.